CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS.

MLA

Çebi, Merve, et al. “CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS.” Frontiers in Immunology, vol. 11, May 2020, pp. 1–16. EBSCOhost, https://doi.org/10.3389/fimmu.2020.00809.

APA

Çebi, M., Durmus, H., Aysal, F., Özkan, B., Gül, G. E., Çakar, A., Hocaoglu, M., Mercan, M., Yentür, S. P., Tütüncü, M., Yayla, V., Akan, O., Dogan, Ö., Parman, Y., & Saruhan-Direskeneli, G. (2020). CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS. Frontiers in Immunology, 11, 1–16. https://doi.org/10.3389/fimmu.2020.00809

Chicago

Çebi, Merve, Hacer Durmus, Fikret Aysal, Berker Özkan, Gizem Engin Gül, Arman Çakar, Mehmet Hocaoglu, et al. 2020. “CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS.” Frontiers in Immunology 11 (May): 1–16. doi:10.3389/fimmu.2020.00809.